UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kinesin KIF4 Regulates Intracellular Trafficking and Stability of the Human Immunodeficiency Virus Type 1 Gag Polyprotein

Journal of Virology, 2008-10, Vol.82 (20), p.9937-9950

2008

Volltextzugriff (PDF)

HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR

BMC molecular biology, 2007-07, Vol.8 (1), p.63-63

2007

Volltextzugriff (PDF)

Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5

Journal of Virology, 2013-03, Vol.87 (5), p.2401-2411

2013

Volltextzugriff (PDF)

Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors

Journal of Virology, 2011-08, Vol.85 (16), p.8227-8240

2011

Volltextzugriff (PDF)

V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc

Virology (New York, N.Y.), 2012-06, Vol.427 (2), p.158-165

2012

Volltextzugriff (PDF)

Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants

Journal of Virology, 2013-06, Vol.87 (12), p.6569-6581

2013

Volltextzugriff (PDF)

Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry

PLoS pathogens, 2009-08, Vol.5 (8), p.e1000548-e1000548

2009

Volltextzugriff (PDF)

Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR

Retrovirology, 2008-05, Vol.5 (1), p.40-40, Article 40

2008

Volltextzugriff (PDF)

Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin

Retrovirology, 2006-01, Vol.3 (1), p.4-4, Article 4

2006

Volltextzugriff (PDF)

Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription

Retrovirology, 2006-11, Vol.3 (1), p.78-78, Article 78

2006

Volltextzugriff (PDF)

Acetylated Tat Regulates Human Immunodeficiency Virus Type 1 Splicing through Its Interaction with the Splicing Regulator p32

Journal of Virology, 2006-04, Vol.80 (7), p.3189-3204

2006

Volltextzugriff (PDF)

Identifying the Membrane Proteome of HIV-1 Latently Infected Cells

The Journal of biological chemistry, 2007-03, Vol.282 (11), p.8207-8218

2007

Volltextzugriff (PDF)

The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation

Oncogene, 2005-01, Vol.24 (4), p.525-540

2005

Volltextzugriff (PDF)

CDK13, a New Potential Human Immunodeficiency Virus Type 1 Inhibitory Factor Regulating Viral mRNA Splicing

Journal of Virology, 2008-07, Vol.82 (14), p.7155-7166

2008

Volltextzugriff (PDF)

Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics

Current pharmaceutical design, 2006-06, Vol.12 (16), p.1949-1961

2006

Volltextzugriff (PDF)

Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists

Antimicrobial Agents and Chemotherapy, 2012-04, Vol.56 (4), p.1931-1935

2012

Volltextzugriff (PDF)

Oxadiazols: a New Class of Rationally Designed Anti-Human Immunodeficiency Virus Compounds Targeting the Nuclear Localization Signal of the Viral Matrix Protein

Journal of Virology, 2005-10, Vol.79 (20), p.13028-13036

2005

Volltextzugriff (PDF)

Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways

AIDS research and therapy, 2008-06, Vol.5 (1), p.12-12, Article 12

2008

Volltextzugriff (PDF)

RNA interference directed to CDK2 inhibits HIV-1 transcription

Virology (New York, N.Y.), 2005-10, Vol.341 (2), p.171-178

2005

Volltextzugriff (PDF)

Corrigendum to “V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc” [Virology 427 (2012) 158–165]

Virology (New York, N.Y.), 2012-06, Vol.428 (1), p.76-76

2012

Volltextzugriff (PDF)

Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry: e1000548

PLoS pathogens, 2009-08, Vol.5 (8)

2009

Volltextzugriff (PDF)

Role of viral regulatory and accessory proteins in HIV-1 replication

Frontiers in bioscience, 2004-09, Vol.9 (1-3), p.2388

2004

Volltextzugriff (PDF)

The role of acetylated Tat in HIV-1 mRNA splicing

Berro, Reem

2007

Volltextzugriff (PDF)

Mechanisms of HTLV-1 transformation

Frontiers in bioscience, 2004, Vol.9 (1-3), p.2347

2004

Volltextzugriff (PDF)

Identifying membrane protein surface markers of HIV-1 infection

Future HIV therapy, 2008-03, Vol.2 (2), p.155-165

2008

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Kinesin KIF4 Regulates Intracellular Trafficking and Stability of the Human Immunodeficiency Virus Type 1 Gag Polyprotein

HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR

Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5

Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors

V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc

Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants

Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry

Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR

Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin

Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription

Acetylated Tat Regulates Human Immunodeficiency Virus Type 1 Splicing through Its Interaction with the Splicing Regulator p32

Identifying the Membrane Proteome of HIV-1 Latently Infected Cells

The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation

CDK13, a New Potential Human Immunodeficiency Virus Type 1 Inhibitory Factor Regulating Viral mRNA Splicing

Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics

Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists

Oxadiazols: a New Class of Rationally Designed Anti-Human Immunodeficiency Virus Compounds Targeting the Nuclear Localization Signal of the Viral Matrix Protein

Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways

RNA interference directed to CDK2 inhibits HIV-1 transcription

Corrigendum to “V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc” [Virology 427 (2012) 158–165]

Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry: e1000548

Role of viral regulatory and accessory proteins in HIV-1 replication

The role of acetylated Tat in HIV-1 mRNA splicing

Mechanisms of HTLV-1 transformation

Identifying membrane protein surface markers of HIV-1 infection

Suchergebnisse filtern